本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

5.53
+0.19003.56%
盘后:5.530.00000.00%19:30 EDT
成交量:5.73万
成交额:31.27万
市值:3,453.26万
市盈率:-0.76
高:5.64
开:5.50
低:5.30
收:5.34
52周最高:13.69
52周最低:3.98
股本:624.46万
流通股本:368.17万
量比:2.25
换手率:1.56%
股息:- -
股息率:- -
每股收益(TTM):-7.3016
每股收益(LYR):-2.4500
净资产收益率:-113.59%
总资产收益率:-49.12%
市净率:1.08
市盈率(LYR):-2.26

数据加载中...

2022/03/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/06

重要事件披露

8-K - Current report
2021/11/18

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/11/18

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/28

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/24

重要事件披露

8-K - Current report
2021/06/24

重要事件披露

8-K/A [Amend] - Current report